FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
Innovative Therapies and Personalized Medicine for Rare Diseases: MOOC in Full Swing
As we are in full swing of the facilitation window in September, we're excited to share an update on the ongoing online [...]
Newsletter, June 2024
Dear Reader, Imagine a world where every child, regardless of their condition, has access to safe, effective, and child-friendly therapies. This [...]
RACE Act accelerates Paediatric Oncology Drug Testing, FDA reports
The U.S. Food and Drug Administration (FDA) has reported a significant increase in the number of planned studies to test drugs [...]
DEEP-2 Lay Summaries for Children and Teens
Thanks to the collaboration with the TEDDY Network, CVBF has published two new lay summaries explaining the key findings [...]
CVBF’s New Video Offers Insights into Multinational Rare Disease Clinical Trials
We are proud to share with you the newly released informative video detailing the challenges and strategies involved in conducting [...]
CVBF at the ERAMET Kick-Off Meeting
Namur, Belgium - CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was [...]
29 February 2024, Rare Disease Day
29 February is Rare Disease Day, falling on the rarest date of the calendar. This is an opportunity to raise [...]
New Clinical Trial Seeks to Slow Progression of Nearsightedness in Children
A new international clinical trial is underway across Europe to test whether low-dose atropine eye drops can effectively slow the progression of myopia (nearsightedness) in [...]
13 Organizations Across Europe Join Forces for Novel ATMP on Faecal incontinence.
CVBF provides regulatory, site management, and monitoring support for the AMELIE (Anchored Muscle cELls for IncontinencE) project, Ana Dilo as our Clinical Project Manager of [...]
New Article on Gabapentin and Tramadol in Paediatric Patients with Chronic Pain
A new article published on 6 October 2023 in the Journal of the British Pharmacological Society titled"Dose rationale for gabapentin and tramadol in paediatric patients [...]
Quality Assurance Head, Mariagrazia Felisi, Leads Workshop on EU Clinical Trial Regulation
On 27 June 2023, Mariagrazia Felisi, our Quality Assurance Head and Internal Auditor, co-chairing the "AICRO Clinical Trial Center Working Group", opened and led the [...]
Advanced Therapies: A Researcher’s Perspective on ATMPs – Insights from Giovanni Migliaccio
Giovanni Migliaccio, the Scientific Director of CVBF, recently participated at the MEP Interest Group 2023 Conference organized by the European Alliance for Transformative Therapies (TRANSFORM) [...]
EUCROF Paediatric Training: Our CEO’s Vision for Advancing Paediatric Clinical Research
In the ever-advancing world of clinical research, staying at the forefront of knowledge and practices is imperative. On 12 September 2023, our CEO, Donato Bonifazi [...]